Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated the secretion of the matrix metalloproteinases,
interstitial collagenase
(matrix metalloproteinase-1), gelatinase A (matrix metalloproteinase-2) and stromelysin-1 (matrix metalloproteinase-3) in human synovial fibroblasts after stimulation with the neuropeptide
substance P
. Human synovial fibroblasts were stimulated with
substance P
or interleukin-1 beta (IL-1 beta). In the cell culture media gelatinase A,
interstitial collagenase
and stromelysin-1 were identified and their activities towards different substrates were determined.
Substance P
in synovial fibroblasts induced an increase in the overall matrix metalloproteinase activity towards the dinitrophenyl-labelled peptide by 85%, against an increase of 124% after stimulation with IL-1 beta. In case of
substance P
stimulation, the increase in activity reflects a significantly enhanced secretion of gelatinase A, whereas no significant increase of stromelysin-1 and collagenase secretion could be observed. The matrix metalloproteinase pattern showing the highest gelatinase A secretion was obtained after stimulation with
substance P
. This pattern was very pronounced and differed very clearly from the pattern seen after IL-1 beta stimulation which caused a significant rise in collagenase and stromelysin-1 activity. We assume that distinct stimulation pathways are involved and that the neuropeptide (
substance P
), which is always present in the inflamed joint, plays its own and separate role in proliferative processes leading to the cartilage destruction.
...
PMID:Substance P induces the secretion of gelatinase A from human synovial fibroblasts. 935 27